The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

The chief medical officer is interested in an easier path to market for health screening features in wearable devices.

Under the agreement, the engineering partner will be responsible for a significant portion of the software development for ...

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the ...

Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech ...

Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures. Edwards’ Pascal and Abbott’s MitraClip ...

If finalized, the changes would reduce the scope of AI regulations for medical devices and include more provisions for rare disease treatments.

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...

The company received three complaints about patients who had perforation injuries linked to the devices.

The request for information comes as the Trump administration has largely taken a deregulatory stance on AI, in a bid to ...

Abbott can now compete with Medtronic, Boston Scientific and J&J in the U.S. for the fast-growing pulsed field ablation market.